Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes

Diabetic Medicine

Volumn 33, Issue 4, 2016, Pages 511-514

  Dujic, T ^a   Causevic, A ^a   Bego, T ^a   Malenica, M ^a   Velija Asimi, Z ^b   Pearson, E R ^c   Semiz, S ^a,d  

^a UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

^b University Clinical Centre of Sarajevo   (Bosnia and Herzegovina)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d INTERNATIONAL UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; CLOPIDOGREL; CREATININE; DOXAZOSIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; ORGANIC CATION TRANSPORTER 1; PROTON PUMP INHIBITOR; TRAMADOL; TRIACYLGLYCEROL; VERAPAMIL; ANTIDIABETIC AGENT;

ADULT; ALLELE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DNA POLYMORPHISM; FEMALE; GASTROINTESTINAL SYMPTOM; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL; AGED; AMINO ACID SUBSTITUTION; BOSNIA AND HERZEGOVINA; CHEMICALLY INDUCED; COHORT ANALYSIS; DIABETES MELLITUS, TYPE 2; GASTROENTERITIS; GENE DELETION; GENETIC ASSOCIATION STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; SEXUAL DEVELOPMENT;

AGED; ALLELES; AMINO ACID SUBSTITUTION; BOSNIA AND HERZEGOVINA; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GASTROENTERITIS; GENE DELETION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; ORGANIC CATION TRANSPORTER 1; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX CHARACTERISTICS;

EID: 84961136385     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.13040     Document Type: Article

References (12)

1. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M et al. Management of hyperglycemia in Type 2 diabetes, 2015: a patient-centered approach: update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015; 38: 140-149.
2. Kirpichnikov D, McFarlane SI, Sowers JR. Metformin: an update. Ann Intern Med 2002; 137: 25-33.
3. Dujic T, Zhou K, Donnelly LA, Tavendale R, Palmer CN, Pearson ER. Association of organic cation transporter 1 with intolerance to metformin in Type 2 diabetes: a GoDARTS study. Diabetes 2015; 64: 1786-1793.
4. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
5. Nies AT, Koepsell H, Damme K, Schwab M. Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy. Handb Exp Pharmacol 2011; 201: 105-167.
6. Florez H, Luo J, Castillo-Florez S, Mitsi G, Hanna J, Tamariz L et al. Impact of metformin-induced gastrointestinal symptoms on quality of life and adherence in patients with type 2 diabetes. Postgrad Med 2010; 122: 112-120.
7. Bouchoucha M, Uzzan B, Cohen R. Metformin and digestive disorders. Diabetes Metab 2011; 37: 90-96.
8. Tarasova L, Kalnina I, Geldnere K, Bumbure A, Ritenberga R, Nikitina-Zake L et al. Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients. Pharmacogenet Genomics 2012; 22: 659-666.
9. Shu Y, Sheardown SA, Brown C, Owen RP, Zhang S, Castro RA et al. Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J Clin Invest 2007; 117: 1422-1431.
10. Wilcock C, Bailey CJ. Accumulation of metformin by tissues of the normal and diabetic mouse. Xenobiotica 1994; 24: 49-57.
11. Muller J, Lips KS, Metzner L, Neubert RH, Koepsell H, Brandsch M. Drug specificity and intestinal membrane localization of human organic cation transporters (OCT). Biochem Pharmacol 2005; 70: 1851-1860.
12. Han TK, Everett RS, Proctor WR, Ng CM, Costales CL, Brouwer KL et al. Organic cation transporter 1 (OCT1/mOct1) is localized in the apical membrane of Caco-2 cell monolayers and enterocytes. Mol Pharmacol 2013; 84: 182-189.